Ziprasidone-induced galactorrhea: A case report

Neuroendocrinology Letters

Volumn 26, Issue 1, 2005, Pages 69-70

  Kopeĉek, Miloslav ^a,b   Bareŝ, Martin ^a,b   Mohr, Pavel ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Galactorrhea; Prolactin; Side effects; Ziprasidone

Indexed keywords

CLONAZEPAM; DOPAMINE 2 RECEPTOR; LIOTHYRONINE; LITHIUM; NEUROLEPTIC AGENT; PROLACTIN; THYROTROPIN; THYROXINE; ZIPRASIDONE;

ADULT; ARTICLE; AUTOMUTILATION; AWARENESS; CASE REPORT; CAUCASIAN; DEPRESSION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; PSYCHIATRIST; RECEPTOR BLOCKING; SYMPTOM;

EID: 15444373431     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Apseloff G, Mullet D, Wilner KD, Anziano RJ, Tensfeldt TG, Pelletier SM et al. The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium Br J Clin Pharmacol 2000; 49 Suppl 1:61S-64S.
2. Coulouvrat C, Dondey-Nouvel L. Safety of amisulpride (Solian): a review of 11 clinical studies. Int Clin Psychopharmacology 1999 Jul; 14(4):209-18.
3. Grandison L. Suppression of prolactin secretion by benzodiazepines in vivo. Neuroendocrinology 1982; 34(5):369-73.
4. Jordan MP. Ziprasidone-associated galactorrhea in a female teenager. J Am Acad Child Adolesc Psychiatry 2003 Jan; 42(1):4-5.
5. Kleinberg DL, Davis JM, De Coster R, Van Baelen B, Brecher M. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacology 1999 Feb; 19(1):57-61.
6. Kopeček M, Bareš M, Švarc J, Dockery C, Horáček J. Hyperprolactinemia after low dose of Amisulpride. Neuroendocrinol Lett 2004 in press.
7. Licht RW, Arngrim T, Cristensen H. Olanzapine-induced galactorrhea. Psychopharmacology (Berl) 2002 Jun;162(1):94-5.
8. Mendhekar DN, Lohia D, Jiloha RC. Olanzapine-induced galactorrhea in a woman with psychotic illness. Aust N Z J Psychiatry 2004 Apr; 38(4):266.
9. Miceli JJ, Wilner KD, Hansen RA, Johnson AC, Apseloff G, Gerber N. Single- and multiple-dose pharmacokinetics of ziprasidone under non- fasting conditions in healthy male volunteers. Br J Clin Pharmacol 2000; 49 Suppl 1:5S-13S.
10. Petty RG. Prolactin and antipsychotic medications: Mechanism of action. Schizophr Res 1999; 35 Mar 1; Suppl:S67-73.